+44 1865 248455
info@oxfordglobal.co.uk
Enquire
Twitter
Linkedin-in
Biologics UK: In-Person
: Speakers
Speakers
21 – 22 March 2022 | London, UK
+ Digital Day: 23 March 2022 | Online
Part of the
Biologics Series
Biologics UK:
In-Person
Oligonucleotide Chemistry & Therapeutics Symposium
Antibody Engineering:
Online
Vaccines Europe:
In-Person
Home
Agenda
Speakers
Sponsorship
Attendees
Media Partners
Plan Your Visit
Menu
Home
Agenda
Speakers
Sponsorship
Attendees
Media Partners
Plan Your Visit
Book Now
Biologics UK: In-Person
has now concluded. Please click here for more information on other events within our
Biologics Series
, taking place throughout the year.
Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.
The following are confirmed speakers for Biologics UK: In-Person 2022
Alessandro Sannino
Senior Expert Science & Technology
Novartis
Alex MacPherson
Senior Principle Scientist
UCB
Ali Tavassoli
Chief Scientific Officer, Professor
Curve Therapeutics, University of Southampton
Amy Doty
Associate Principal Scientist
MSD
Andrew Argo
Scientist I
Biogen
Angus Sinclair
Senior Vice President, Immuno-Oncology
IGM Biosciences
Anna Hine
Professor
Aston University
Barbara Hebeis
Director, Bioassay
AstraZeneca
Colette Johnston
Senior Director, Early Discovery
Crescendo Biologics
Dan Bach Kristensen
Principal Scientist , Analytics and Formulation
Symphogen
Daniel Fleischanderl
Head of Upstream Development (Microbial) / Director
Boehringer-Ingelheim
David Humphries
Senior Director, New Modalities and Therapeutics.
UCB
Denice Chan
Senior Scientist
Cancer Research UK - AstraZeneca Antibody Alliance Laboratory
Denis Drygin
Chief Scientific Officer
Regulus Therapeutics
Dilyana Dimova
Data Scientist
Sanofi
Dmitry Samarsky
Chief Technology Officer
Sirnaomics
Enkelejda Miho
Professor
University of Applied Sciences and Arts Northwestern Switzerland
Ernst Weber
Head of Molecular Design & Engineering
Bayer AG
Francis Duffieux
Head of Protein Purification and Microbial Fermentation
Sanofi
Francois Bertelli
Head of Platform Development
Avvinity
Gene Liau
Chief Scientific Officer
Stoke Therapeutics
Harald Kolmar
Professor
Technical University of Darmstadt
Helen Payne
Senior Scientist, High Throughput Characterisation
GlaxoSmithKline
Hetal Sarvaya
Associate Director, DMPK-BA
AbbVie
Ijeoma Florence Uchegbu
Professor of Pharmaceutical Nanoscience
University College London
Ilias Jimidar
Associate Director, Scientific Integration
Janssen
Immanuel Lerner
Chief Executive Officer
Pepticom
Jeffrey Luo
Associate Scientific Director
Janssen
Joël Richard
Executive Committee Member - Chief Development Officer
MedInCell
Katerine van Rietschoten
Team Leader - Peptide Chemistry
Bicycle Therapeutics
Katrin Reichel
Senior Data Scientist
Sanofi
Katrina Campbell
Professor
Queen's University Belfast
Keith Foster
Chief Scientific Officer
Sutura Therapeutics
Kevin McDonnell
Vice President, Chemistry, US
Bicycle Therapeutics
Kristian Stromgaard
Chief Executive Officer/Professor
Avilex Pharma/University of Copenhagen
Laura von Schantz
VP Discovery
Alligator Bioscience AG
Laure Bouchez
Senior Director
Worg Pharma
Mahendra Deonaraian
Chief Executive and Science Officer
Antikor Biopharma Ltd
Manoj Pal
Principal Scientist, Analytical & Formulation Development
Ambrx
Marc Vendrell
Professor
University of Edinburgh
Marlon Hinner
Principal Scientist
Roche Pharmaceuticals
Martin Akerman
Chief Technology Officer, Co-Founder
Envisagenics
Michael Keller
Senior Principle Scientist
Roche
Michaela Blech
Associate Director of Global Pharmaceutical Development
Boehringer Ingelheim
Min Fang
Senior Scientist
National Institute for Biological Standards and Control
Nagy Habib
Founder, Head of R&D
MiNA Therapeutics
Naresh Badgujar
Associate Principal Scientist
AstraZeneca
Neeraj Agrawal
Principal Scientist and Group Leader
Amgen
Neil Birkett
Process Development Lead
Crescendo Biologics
Nicholas Mitchell
Assistant Professor & Group Leader
University of Nottingham
Nicolas Basse
Head of immuno-oncology cluster
Sanofi
Nigel Davies
Principal Scientist
AstraZeneca
Paul Dalby
Professor
University College London
Peter Molloy
Director of Proteins Science Research
Immunocore
Peter Slavny
Chief Technology Officer
Iontas
Punit Seth
Senior Vice President
Alnylam Pharmaceuticals
Robin Loving
Chief Scientific Officer
Salipro Biotech AG
Sarah Lovelock
UKRI Future Leaders Fellow
University of Manchester
Sebastien Violini
Scientist, Technical Research & Development
Roche Pharmaceuticals
Sergio Mallart
Principle Scientist
Sanofi
Silvia Sonzini
Associate Principle Scientist
AstraZeneca
Stefan Zielonka
Associate Director; Protein Engineering & Antibody Technologies
Merck KGaA
Steve Hood
Senior Scientific Director, Imaging Expertise Networks
GlaxoSmithKline
Steven Grant
Manager, Biopharm Molecular Discovery
GlaxoSmithKline
Suzanne Bal
Scientist
Merus
Tanja Gaissmaier
Scientist, Potency Skill Center
Boehringer Ingelheim
Tom Brown
Professor of Nucleic Acid Chemistry
University of Oxford
Tomas Leek
Director
AstraZeneca
Trevor Wilkinson
Associate Director
AstraZeneca
Wu Su
Team Leader and Director of Medicinal Chemistry
AstraZeneca
Yi Yang
Lead Scientist
Ferring Pharmaceuticals